Skip to main content
SpringerLink
Log in

Diagnosis and Treatment of Geriatric Depression

  • Disease Management
  • Published:
CNS Drugs Aims and scope Submit manuscript

Summary

Geriatric depression is a common psychiatric illness affecting as many as one-third of the older population. With the growing number of elderly in many countries of the world, the morbidity and mortality associated with untreated and partially treated depression is of great concern from both a medical and economic perspective.

Depression in the elderly often presents with more somatic or anxious features and less of the subjective sadness expressed by younger groups. In addition, in the elderly, depressive-spectrum disorders (which include minor depression, dysthymia, mixed anxiety/depression, bereavement-related depression and even suicidal ideation) are generally under-recognised and undertreated by health professionals.

The clinical mismatch between high prevalence but undertreatment stems from patient and physician attitudes toward depression as a ‘normal’ response to aging and loss, diagnostically confusing medical illness-related symptomatology, and noncompliance with prescribed treatment. Furthermore, late-onset depression may hold special prognostic value in the elderly, with the relationship between late-onset depression and cerebrovascular events and progressive dementing illness being particularly strong.

Therapeutically, there has been a recent expansion in the pharmacological tools that can be used to treat depression. A variety of new agents are now available that have adverse effect, pharmacodynamic and target-receptor profiles that differ from the older agents. For example, newer drugs that block the serotonin (5-hydroxytryptamine; 5-HT) transporter have supplanted older agents that cause more frequent and toxic adverse effects. These newer agents have also focused attention on the impact of polypharmacy on the hepatic cytochrome P450 system, which is responsible for drug metabolism and elimination. Electroconvulsive therapy and psychotherapy remain effective nonpharmacological treatments for geriatric depression.

Generally, the opportunities for therapeutic intervention in geriatric depression suggest that greater diagnostic attention and more widespread application of treatments for this increasingly prevalent disorder continue to be needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. United Nations Statistical Office. Demographic yearbook. New York: Department of Economic and Social Affairs, United Nations, 1993: 142–53

    Google Scholar 

  2. United States, Bureau of the Census. Statistical abstract of the United States. 115th ed. Washington, DC: US Department of Commerce, 1995: 88–9

    Google Scholar 

  3. Bland RC, Newman SC, Orn H. Period prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand 1988; 77: 43–9

    Article  Google Scholar 

  4. Robins LN, Regier DA. Psychiatric disorders in America: the Epidemiological Catchment Area study. New York: The Free Press, MacMillan Inc, 1991

    Google Scholar 

  5. Henderson AS, Jorm AF, Mackinnon A, et al. The prevalence of depressive disorders and the distribution of depressive symptoms in later life: a survey using Draft ICD-10 and DSM-III-R. Psychol Med 1993; 23(3): 719–29

    Article  PubMed  CAS  Google Scholar 

  6. Slater SL, Katz IR. Prevalence of depression in the aged: formal calculations versus clinical facts. J Am Geriatr Soc 1995; 43: 78–9

    PubMed  CAS  Google Scholar 

  7. Rovner BW, German PS, Brant LJ, et al. Depression and mortality in nursing homes. JAMA 1991 Feb 27; 265(8): 993–6

    Article  PubMed  CAS  Google Scholar 

  8. Parmelee PA, Katz IR, Lawton MR. Incidence of depression long-term care settings. J Gerontol 1992; 47(6): M189–96

    PubMed  CAS  Google Scholar 

  9. Blazer D. The epidemiology of depression in late life. J Geriatr Psychiatry 1989; 22: 35–52

    PubMed  CAS  Google Scholar 

  10. Ernst C, Angst J. Depression in old age: is there a real decrease in prevalence? A review. Eur Arch Psychiatry Clin Neurosci 1995; 245: 272–87

    Article  PubMed  CAS  Google Scholar 

  11. Knäuper B, Wittchen HU. Diagnosing major depression in the elderly: evidence for response bias in standardized diagnostic interviews? J Psychiatr Res 1994; 28(2): 147–64

    Article  PubMed  Google Scholar 

  12. Martin LM, Fleming KC, Evans JM. Recognition and management of anxiety and depression in elderly patients. Mayo Clin Proc 1995; 70: 999–1006

    Article  PubMed  CAS  Google Scholar 

  13. Richardson JP, Gallo JJ. Geriatrics for the clinician: treatment of depression in the elderly. Md Med J 1996 Jul; 45(7): 553–6

    PubMed  CAS  Google Scholar 

  14. Devanand DP, Nobler MS, Singer T, et al. Is dysthymia a different disorder in the elderly? Am J Psychiatry 1994 Nov; 151(11): 1592–9

    PubMed  CAS  Google Scholar 

  15. Kennedy GJ. The geriatric syndrome of late-life depression. Psychiatr Serv 1995 Jan; 46(1): 43–8

    PubMed  CAS  Google Scholar 

  16. Lebowitz BD, Martinez RA, Niederehe G, et al. Treatment of depression in late life: NIMH/MacArthur Foundation Workshop report. Psychopharmacol Bull 1995; 31(1): 185–202

    PubMed  CAS  Google Scholar 

  17. Tannock C, Katona C. Minor depression in the aged. Drugs Aging 1995; 6(4): 278–92

    Article  PubMed  CAS  Google Scholar 

  18. Blazer D, Hughes DC, George LK. The epidemiology of depression in an elderly community sample. Gerontologist 1987; 27: 281–7

    Article  PubMed  CAS  Google Scholar 

  19. Katz IR, Lesher E, Kleban M, et al. Clinical features of depression in the nursing home. Int Psychogeriatr 1989; 1(1): 5–15

    Article  PubMed  CAS  Google Scholar 

  20. Howland RH, Thase ME. Biological studies of dysthymia. Biol Psychiatry 1991 Aug 1; 30(3): 283–304

    Article  PubMed  CAS  Google Scholar 

  21. Hellerstein DJ, Yanowitch P, Rosenthal J, et al. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 1993; 150: 1169–75

    PubMed  CAS  Google Scholar 

  22. Wells KB, Burnam MA, Rogers W, et al. The course of depression in adult outpatients: results from the medical outcomes study. Arch Gen Psychiatry 1992 Oct; 49: 788–94

    Article  PubMed  CAS  Google Scholar 

  23. Koenig HG, Blazer DG III. Minor depression in late-life. Am J Geriatr Psychiatry 1996; 4Suppl. 1: S14–21

    Google Scholar 

  24. Kivelä SL. Long-term prognosis of major depression in old-age: a comparison with prognosis of dysthymic disorder. Int Psychogeriatr 1995; 7: 69–82

    Article  PubMed  Google Scholar 

  25. Rothschild AJ. The diagnosis and treatment of late-life depression. J Clin Psychiatry 1996; 57Suppl. 5: 5–11

    PubMed  Google Scholar 

  26. Brodaty H. Think of depression: atypical presentations in the elderly. Aust Fam Physician 1993 Jul; 22(7): 1195–203

    PubMed  CAS  Google Scholar 

  27. Bonner D, Howard R. Treatment-resistant depression in the elderly. Int Psychogeriatr 1995; 7: 83–94

    Article  PubMed  Google Scholar 

  28. Baron M, Mendlewicz J, Klotz J. Age-of-onset and genetic transmission of affective disorders. Acta Psychiatr Scand 1981; 64: 373–80

    Article  PubMed  CAS  Google Scholar 

  29. Fava M, Alpert JE, Bonis JS, et al. Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. Am J Psychiatry 1996 Oct; 153(10): 1308–12

    PubMed  CAS  Google Scholar 

  30. Ranga Rama Krishnan K, Gadde KM. The pathophysiologic basis for late-life depression. Am J Geriatr Psychiatry 1996; 4Suppl. 1: S22–33

    Google Scholar 

  31. Folstein SE, Peyser CE, Starkstein SE, et al. Subcortical triad of Huntington’s disease: a model for a neuropathology of depression, dementia, and dyskinesia. In: Carroll BJ, Barrett JE, editors. Psychopathology and the brain. New York: Raven Press, 1991: 65–75

    Google Scholar 

  32. Coffey CE, Figiel GS. Neuropsychiatric significance of subcortical encephalomalacia. In: Carroll BJ, Barrett JE, editors. Psychopathology and the brain. New York: Raven Press, 1992: 243–64

    Google Scholar 

  33. Cummings J. Depression and Parkinson’s disease: a review. Am J Psychiatry 1992; 149: 443–54

    PubMed  CAS  Google Scholar 

  34. Ranga Rama Krishnan K. Neuroanatomic substrates of depression in the elderly. J Geriatr Psychiatry Neurol 1993 Jan-Mar; 6: 39–58

    Google Scholar 

  35. Figiel GS, Rama Ranga Krishnan K, Doraiswamy PM, et al. Subcortical hyperintensities on brain MRI: a comparison between late age onset and early onset elderly depressed subjects. Neurobiol Aging 1991; 26: 245–7

    Article  Google Scholar 

  36. Alexopoulos GS, Young RC, Shindledecker R. Brain computed tomography in geriatric depression and primary degenerative dementia. Biol Psychiatry 1992; 31: 591–9

    Article  PubMed  CAS  Google Scholar 

  37. Lesser IM, Boone KB, Mehringer CM, et al. Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry 1996; 153: 1280–7

    PubMed  CAS  Google Scholar 

  38. Salloway S, Malloy P, Kohn R, et al. MRI and neuropsychologi-cal differences in early- and late-onset geriatric depression. Neurology 1996 Jun; 46: 1567–74

    Article  PubMed  CAS  Google Scholar 

  39. Ranga Rama Krishnan K, Turpler LA, Ritchie JC, et al. Apolipoprotein E-e4 frequency in geriatric depression. Biol Psychiatry 1996; 40: 69–71

    Article  Google Scholar 

  40. Reding M, Haycox J, Blass J. Depression in patients referred to a dementia clinic: a three-year prospective study. Arch Neurol 1986; 42: 894–6

    Article  Google Scholar 

  41. Kral VA, Emery OB. Long-term follow-up of depressed pseudodementia of the aged. Can J Psychiatry 1988 Jun; 34(5): 445–6

    Google Scholar 

  42. Alexopoulos GS, Meyers BS, Young RC, et al. The course of geriatric depression with ‘reversible dementia’: a controlled study. Am J Psychiatry 1993 Nov; 150(11): 1693–9

    PubMed  CAS  Google Scholar 

  43. Alexopoulos GS, Young RC, Meyers BS. Geriatric depression: age of onset and dementia. Biol Psychiatry 1993; 34: 141–5

    Article  PubMed  CAS  Google Scholar 

  44. Boone KB, Lesser I, Miller B, et al. Cognitive functioning in a mildly to moderately depressed geriatric sample: relationship to chronological age. J Neuropsychiatry 1994 Summer; 6(3): 267–72

    CAS  Google Scholar 

  45. Wells KB, Stewart A, Hays RD, et al. The functioning and wellbeing of depressed patients: results from the medical outcomes study. JAMA 1989; 262: 914–9

    Article  PubMed  CAS  Google Scholar 

  46. Caine ED, Lyness JM, Conwell Y. Diagnosis of late-life depression. Am J Geriatr Psychiatry 1996; 4Suppl. 1: S45–50

    Google Scholar 

  47. Newhouse P. Use of serotonin selective reuptake inhibitors in geriatric depression. J Clin Psychiatry 1996; 57Suppl. 5: 12–22

    PubMed  CAS  Google Scholar 

  48. Conwell Y. Outcomes of depression. Am J Geriatr Psychiatry 1996; 4Suppl. 1: S34–44

    Google Scholar 

  49. Rovner BW. Depression and increased risk of mortality in the nursing home patient. Am J Med 1993 May 24; 94Suppl. 5A: 19S–22S

    PubMed  CAS  Google Scholar 

  50. Alexopoulos GS, Vrontou C, Kakuma T, et al. Disability in geriatric depression. Am J Psychiatry 1996 Jul; 153(7): 877–85

    PubMed  CAS  Google Scholar 

  51. Brodaty H, Harris L, Peters K, et al. Prognosis of depression in the elderly. Br J Psychiatry 1993; 163: 589–96

    Article  PubMed  CAS  Google Scholar 

  52. Alexopoulos GS, Meyers BS, Young RC, et al. Recovery in geriatric depression. Arch Gen Psychiatry 1996 Apr; 53: 305–12

    Article  PubMed  CAS  Google Scholar 

  53. Reynolds III CF, Frank E, Kupfer DJ, et al. Treatment outcome in recurrent major depression: a post hoc comparison of elderly (‘young old’) and midlife patients. Am J Psychiatry 1996; 153: 1288–92

    PubMed  Google Scholar 

  54. Farrell KR, Ganzini L. Misdiagnosing delirium as depression in medically ill elderly patients. Arch Intern Med 1995 Dec 11; 155: 2459–64

    Article  PubMed  CAS  Google Scholar 

  55. Kalchthler T, Coccaro E, Lichtiger S. Incidence of polypharmacy in a long-term care facility. J Am Geriatr Soc 1977; 25: 308–13

    Google Scholar 

  56. Everitt DE, Avorn J. Drug prescribing for the elderly. Arch Intern Med 1986; 146: 2393–6

    Article  PubMed  CAS  Google Scholar 

  57. Katz IR. Drug treatment of depression in the frail elderly: discussion of the NIH consensus development conference on the diagnosis and treatment of depression in late life. Psychopharmacol Bull 1993; 29(1): 101–8

    PubMed  CAS  Google Scholar 

  58. Kerremans AL. Cytochrome P450 isoenzymes: importance for the internist. Neth J Med 1996; 48: 237–43

    Article  PubMed  CAS  Google Scholar 

  59. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996 Mar; 153(3): 311–20

    PubMed  CAS  Google Scholar 

  60. Ereshefsky L, Riesenman C, Lam YW. Antidepressant drug interactions and the cytochrome P450 system: the role of cytochrome P450 2D6. Clin Pharmacokinet 1995; 29Suppl. 1: 10–9

    Article  PubMed  CAS  Google Scholar 

  61. Brøsen K. Are pharmacokinetic drug interactions with the SSRIs an issue? Int Clin Psychopharmacol 1996; 11Suppl. 1: 23–7

    Article  PubMed  Google Scholar 

  62. Ketter TA, Flockhart DA, Post RM, et al. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol 1995; 15: 387–98

    Article  PubMed  CAS  Google Scholar 

  63. Knegtering H, Eijck M, Huijsman A. Effects of antidepressants on cognitive functioning of elderly patients: a review. Drugs Aging 1994 Sep; 5(3): 192–9

    Article  PubMed  CAS  Google Scholar 

  64. Oxman TE. Antidepressants and cognitive impairment in the elderly. J Clin Psychiatry 1996; 57Suppl. 5: 38–44

    PubMed  Google Scholar 

  65. Leo R. Movement disorders associated with the serotonin-selective reuptake inhibitors. J Clin Psychiatry 1996; 57: 449–54

    Article  PubMed  CAS  Google Scholar 

  66. Richelson E. The pharmacology of antidepressants at the synapse: focus on newer compounds. J Clin Psychiatry 1994 Sep; 55Suppl. A: 34–9

    PubMed  Google Scholar 

  67. Cusack B, Nelson A, Richelson E. Binding of antidepressants to human brain receptors: focus on the newer generation compounds. Psychopharmacology 1994 May; 114(4): 559–65

    Article  PubMed  CAS  Google Scholar 

  68. Laghrissithode F, Pollock BG, Miller MC, et al. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients. Psychopharmacol Bull 1995; 31(4): 659–63

    CAS  Google Scholar 

  69. Preskorn SH. Recent pharmacologic advances in antidepressant treatment for the elderly. Am J Med 1993 May 24; 94Suppl. 5A: 2–12S

    Google Scholar 

  70. Rosenbaum J. Managing selective serotonin reuptake inhibitordrug interactions in clinical practice. Clin Pharmacokinet 1995; 29Suppl. 1: 53–9

    Article  PubMed  CAS  Google Scholar 

  71. Amsterdam J, Brunswick D, Mendels J. The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. Am J Psychiatry 1980 Jun; 137(6): 653–62

    PubMed  CAS  Google Scholar 

  72. Feighner JP, Cohn JB. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 1985 Mar; 46(3): 20–5

    PubMed  CAS  Google Scholar 

  73. Falk WE, Rosenbaum JF, Otto MW, et al. Fluoxetine versus trazodone in depressed geriatric patients. J Geriatr Psychiatry Neurol 1989; 2(4): 208–14

    Article  PubMed  CAS  Google Scholar 

  74. Guillibert E, Pelcier Y, Archambault JC, et al. A double-blind multicenter study of paroxetine versus clomipramine in depressed elderly subjects. Acta Psychiatr Scand 1989; 80Suppl. 350: 132–4

    Article  Google Scholar 

  75. Cohn CK, Shirvastava R, Mendels J, et al. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990 Dec; 51Suppl. 12B: 28–33

    PubMed  Google Scholar 

  76. Claghorn JL, Feighner JP. A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression. J Clin Psychopharmacol 1993 Dec; 13(6): 23S–7S

    PubMed  CAS  Google Scholar 

  77. Geretsegger C, Stuppaeck CH, Mair M, et al. Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients. Psychopharmacology 1995; 119: 277–81

    Article  PubMed  CAS  Google Scholar 

  78. Miller FT, Freilicher J. Comparison of TCAs and SSRIs in the treatment of major depression in hospitalized geriatric patients. J Geriatr Psychiatry Neurol 1995 Jul; 8: 173–6

    PubMed  CAS  Google Scholar 

  79. Glassman A, Ballenger J, Stokes P, et al. Tricyclic antidepressants: advantages and limitations. Geriatrics 1993 Nov; 48Suppl. 2: 6–8

    Google Scholar 

  80. Roose SP, Glassman AH, Attia E, et al. Comparative efficacy of selective serotonin reuptake inhibitors in the treatment of melancholia. Am J Psychiatry 1994 Dec; 151(12): 1735–9

    PubMed  CAS  Google Scholar 

  81. Baldessarini RJ. Drugs and the treatment psychiatric disorders, depression and mania. In: Molinoff P, Ruddon R, editors. Goodman and Gilman’s the pharmacologic basis of therapeutics. 9th ed. New York: McGraw Hill, 1996: 431–59

    Google Scholar 

  82. Drevets WC. Geriatric depression: brain imaging correlates and pharmacologic considerations. J Clin Psychiatry 1994 Sep; 55Suppl. 9a: 71–81

    PubMed  Google Scholar 

  83. Halikas JA. Org 3770 (mirtazapine) versus trazodone: a placebo-controlled trial in depressed elderly patients. Hum Psychopharmacol 1995; 10: S125–33

    Article  CAS  Google Scholar 

  84. Frazer A. Pharmacology of antidepressants. J Clin Psychopharmacol 1997; 2Suppl. 1: 2–18S

    Article  Google Scholar 

  85. Gurian B, Rosowsky E. Low-dose methylphenidate in the very old. J Geriatr Psychiatry Neurol 1990 Jul-Sep; 3(3): 152–4

    Article  PubMed  CAS  Google Scholar 

  86. Wallace AE, Kofoed LL, West AN. Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. Am J Psychiatry 1995 Jun; 152(6): 929–31

    PubMed  CAS  Google Scholar 

  87. Georgotas A, McCue RE, Friedman E, et al. Response of depressive symptoms to nortriptyline, phenelzine and placebo. Br J Psychiatry 1987; 151: 102–6

    Article  PubMed  CAS  Google Scholar 

  88. Georgotas A, McCue RE, Cooper TB, et al. How effective and safe is continuation therapy in elderly depressed patients? Arch Gen Psychiatry 1988; 45: 929–33

    Article  PubMed  CAS  Google Scholar 

  89. Georgotas A, McCue RE, Cooper TB. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 1989 Sep; 46: 783–6

    Article  PubMed  CAS  Google Scholar 

  90. Sunderland T, Cohen RM, Molchan S, et al. High-dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry 1994 Aug; 51(8): 607–15

    Article  PubMed  CAS  Google Scholar 

  91. Nair NP, Ahmed SK, Ng Ying Kin NM, et al. Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients. Acta Psychiatr Scand 1995; 91Suppl. 386: 28–35

    Article  Google Scholar 

  92. Reynolds III CF, Lebowitz BD, Schneider LS. The NIH consensus development conference on the diagnosis and treatment of depression in late life. Psychopharmacol Bull 1993; 29(1): 83–95

    PubMed  Google Scholar 

  93. Philibert RA, Richards L, Lynch CF, et al. Effect of ECT on mortality and clinical outcome in geriatric unipolar depression. J Clin Psychiatry 1995 Sep; 56(9): 390–4

    PubMed  CAS  Google Scholar 

  94. Thompson LW, Gallagher D, Steinmetz-Breckenridge J. Comparative effectiveness of psychotherapies for depressed elders. J Consult Clin Psychology 1987; 55: 385–90

    Article  CAS  Google Scholar 

  95. Thompson LW. Cognitive-behavioral therapy and treatment for late-life depression. J Clin Psychiatry 1996; 57Suppl. 5: 29–37

    PubMed  Google Scholar 

  96. Steuer JL, Mintz J, Hammen CL, et al. Cognitive-behavioral and psychodynamic group psychotherapy in the treatment of geriatric depression. J Consult Clin Psychology 1984; 52: 80–9

    Article  Google Scholar 

  97. Sadavoy J. Integrated psychotherapy for the elderly. Can J Psychiatry 1994; 39: S19–26

    PubMed  CAS  Google Scholar 

  98. Scogin F, McElreath L. Efficacy of psychosocial treatments for geriatric depression: a quantitative review. J Consult Clin Psychology 1994; 62: 69–74

    Article  CAS  Google Scholar 

  99. Reynolds III CF. Treatment of depression in late life. Am J Med 1994; 97: 39S–46S

    Article  PubMed  Google Scholar 

  100. Reynolds III CF, Frank E, Perel JM, et al. Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report. Am J Psychiatry 1992; 149: 1687–92

    PubMed  Google Scholar 

  101. Reynolds III CF, Frank E, Perel JM, et al. Maintenance therapies for late-life recurrent major depression: research and review circa 1995. Int Psychogeriatr 1995; 7: 27–39

    Article  PubMed  Google Scholar 

  102. Hinrichsen GA, Hernandez NA. Factors associated with recovery from and relapse into major depressive disorder in the elderly. Am J Psychiatry 1993 Dec; 150(12): 1820–5

    PubMed  CAS  Google Scholar 

  103. Kamath M, Finkel SI, Moran MB. A retrospective chart review of antidepressant use, effectiveness, and adverse effects in adults age 70 and older. Am J Geriatr Psychiatry 1996; 4: 167–72

    Article  Google Scholar 

  104. Reynolds III CF, Frank E, Perel JM, et al. Treatment of consecutive episodes of major depression in the elderly. Am J Psychiatry 1994 Dec; 151(12): 1740–3

    PubMed  Google Scholar 

  105. Reynolds III CF. Recognition and differentiation of elderly depression in the clinical setting. Geriatrics 1995 Oct; 50Suppl. 1: S6–15

    PubMed  Google Scholar 

  106. Kushnir SL. Lithium-antidepressant combination in the treatment of depressed, physically ill geriatric patients. Am J Psychiatry 1986; 143: 378–9

    PubMed  CAS  Google Scholar 

  107. Flint AJ, Rifat SL. Aprospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol 1994 Oct; 14(5): 353–6

    Article  PubMed  CAS  Google Scholar 

  108. Weilburg JB, Rosenbaum JF, Biederman J, et al. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry 1989; 50: 447–9

    PubMed  CAS  Google Scholar 

  109. Seth R, Jennings AL, Bindman J, et al. Combination treatment with noradrenaline and serotonin reuptake inhibitors in treatment resistant depression. Br J Psychiatry 1992; 161: 562–5

    Article  PubMed  CAS  Google Scholar 

  110. Reynolds III CF, Frank E, Perel JM, et al. High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression. Am J Psychiatry 1996 Nov; 153(11): 1418–22

    PubMed  Google Scholar 

  111. Jorm AF. The epidemiology of depressive states in the elderly: implications for recognition, intervention and prevention. Soc Psychiatry Psychiatr Epidemiol 1995; 30: 53–9

    Article  PubMed  CAS  Google Scholar 

  112. Lebowitz B. Diagnosis and treatment of depression in late life. Am J Geriatr Psychiatry 1996; 4Suppl. 1: S3–6

    Google Scholar 

  113. Pasternak RE, Reynolds III CF, Schlernitzauer M, et al. Acute open-trial of nortriptyline therapy of bereavement related depression in late life. J Clin Psychiatry 1991; 52: 307–10

    PubMed  CAS  Google Scholar 

  114. Pasternak RE, Reynolds III CF, Frank E, et al. The temporal course of depressive symptoms and grief intensity in late-life spousal bereavement. Depression 1993; 1: 45–9

    Article  Google Scholar 

  115. Jacobs SC, Nelson JC, Zisook S. Treating depressions of bereavement with antidepressants: a pilot study. Psychiatr Clin North Am 1987; 10: 501–10

    PubMed  CAS  Google Scholar 

  116. Prigerson HG, Frank E, Kasl SV, et al. Complicated grief and bereavement-related depression as distinct disorders: preliminary empirical validation in elderly bereaved spouses. Am J Psychiatry 1995 Jan; 152(1): 22–30

    PubMed  CAS  Google Scholar 

  117. Prigerson HG, Bierhals AJ, Kasl SV, et al. Complicated grief as a disorder distinct from bereavement-related depression and anxiety: a replication study. Am J Psychiatry 1996 Nov; 153(11): 1484–6

    PubMed  CAS  Google Scholar 

  118. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994

    Google Scholar 

  119. Blazer DG, Bachar JR, Manton KG. Suicide in late life: review and commentary. J Am Geriatr Soc 1986; 34: 519–25

    PubMed  CAS  Google Scholar 

  120. Kanowski S. Age-dependent epidemiology of depression. Gerontology 1994; 40Suppl. 1: 1–4

    Article  PubMed  Google Scholar 

  121. Danto BL, Danto JM. Psychiatric treatment of the elderly suicidal patient. In: Lester D, Tallmer M, editors. Now I lay me down: suicide in the elderly. Philadelphia: Charles Press, 1994: 43–55

    Google Scholar 

  122. Conwell Y, Rotenberg M, Caine ED. Completed suicide at age 50 and over. J Am Geriatr Soc 1990; 38: 640–4

    PubMed  CAS  Google Scholar 

  123. Lyness JM, Conwell Y, Nelson JC. Suicide attempts in elderly psychiatric inpatients. J Am Geriatr Soc 1992; 40: 320–4

    PubMed  CAS  Google Scholar 

  124. Szanto K, Reynolds III CF, Frank E, et al. Suicide in elderly depressed patients: is active vs passive suicidal ideation a clinically valid distinction? Am J Geriatr Psychiatry 1996; 4: 197–207

    Article  Google Scholar 

  125. Blazer D, Bachar JR, Hughes DC. Major depression with melancholia: a comparison of middle-aged and elderly adults. J Am Geriatr Soc 1987; 35: 927–32

    PubMed  CAS  Google Scholar 

  126. Zweig RA, Hinrichsen GA. Factors associated with suicide attempts by depressed older adults: a prospective study. Am J Psychiatry 1993; 150: 1687–92

    PubMed  CAS  Google Scholar 

  127. Jones JS, Stanley B, Mann JJ, et al. CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. Am J Psychiatry 1990; 147: 1225–7

    PubMed  CAS  Google Scholar 

  128. Nordström P, Samuelsson M, Åsberg M, et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 1994; 24: 1–9

    PubMed  Google Scholar 

  129. McIntosh JL, Santos JF, Hubbard RW, et al. Elder suicide: research, theory, and treatment. Washington, DC: American Psychological Association, 1994: 127–31

    Book  Google Scholar 

  130. Meehan PJ, Saltzman LE, Sattin RW. Suicides among older United States residents: epidemiologic characteristics and trends. Am J Pub Health 1991; 81: 1198–200

    Article  CAS  Google Scholar 

  131. Tallmer M. Symptoms and assessment of suicide in the elderly patient. In: Lester D, Tallmer M, editors. Now I lay me down: suicide in the elderly. Philadelphia: Charles Press, 1994: 17–30

    Google Scholar 

  132. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the scale for suicide ideation. J Consult Clin Psychology 1979; 47: 343–52

    Article  CAS  Google Scholar 

  133. Beck AT, Steer RA, Kovacs M, et al. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 1985; 142: 559–63

    PubMed  CAS  Google Scholar 

  134. Rifai AH, George CJ, Stack JA, et al. Hopelessness in suicide attempters after acute treatment of major depression in late life. Am J Psychiatry 1994; 151: 1687–90

    PubMed  CAS  Google Scholar 

  135. Schifano F. Pharmacological strategies for preventing suicidal behaviour. CNS Drugs 1994; 1(1): 16–25

    Article  Google Scholar 

  136. Murray C, Lopez AD, editors. The global burden of disease. Cambridge (MA): Harvard University Press, 1996: 375–85

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Geriatric Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland, USA

    Robert Lasser, Ruth Dukoff & Trey Sunderland

  2. Department of Psychology, The Catholic University of America, Washington, DC, USA

    Erika Siegel

Authors
  1. Robert Lasser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erika Siegel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ruth Dukoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Trey Sunderland
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lasser, R., Siegel, E., Dukoff, R. et al. Diagnosis and Treatment of Geriatric Depression. Mol Diag Ther 9, 17–30 (1998). https://doi.org/10.2165/00023210-199809010-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199809010-00003

Keywords

Search

Navigation